Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 01, 2023 | SVP International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,400 | $9.64 | 5,954 | |
| Feb 03, 2023 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 555 | $13.43 | 89,026 | |
| Feb 01, 2023 | SVP and General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,137 | $13.36 | 15,730 | |
| Jan 31, 2023 | SVP Global Operations and R&D | Form 4 | Open market or private sale of non-derivative or derivative security | 4,633 | $12.95 | 19,189 | |
| Oct 12, 2022 | EVP and CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,083 | $13.82 | 89,581 | |
| Oct 10, 2022 | Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $15.00 | 450,407 | |
| Jul 29, 2022 | SVP Global Operations and R&D | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $22.44 | 23,822 | |
| Jul 20, 2022 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,060 | -- | 49,461 | |
| Jul 20, 2022 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,987 | -- | 37,754 | |
| Jul 20, 2022 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,974 | -- | 7,974 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.